Donna Arvans
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$3.3MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $3.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 13, 2020 | NIH | STTR Phase II Developing a peptide-based oral drug to prevent kidney stones | $1000K | Oxalo Therapeutics, Inc. |
| Sep 1, 2019 | NIH | STTR Phase II Developing a peptide-based oral drug to prevent kidney stones | $2.0M | Oxalo Therapeutics, Inc. with UNIVERSITY OF CHICAGO |
| Sep 19, 2018 | NIH | STTR Phase II Developing a peptide-based oral drug to prevent kidney stones | $300K | Oxalo Therapeutics, Inc. |
Peer ranks
Federal funding#533
Awards as PI#822
Patents#273
Companies
- Oxalo Therapeutics, Inc.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.